Notice2024-02436
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 7, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 26 (Wednesday, February 7, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 26 (Wednesday, February 7, 2024)]
[Notices]
[Page 8437]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-02436]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the cooperative agreement applications, the disclosure
of which would constitute a clearly unwarranted invasion of personal
privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial
Implementation Cooperative Agreement (U44 Clinical Trial Required);
NIAID Clinical Trial Planning Grants (R34 Clinical Trial Not
Allowed); NIAID Clinical Trial Implementation Cooperative Agreement.
Date: February 29, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3E70A,
Rockville, MD 20892 (Video Assisted Meeting).
Contact Person: Soheyla Saadi, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3E70A, Rockville, MD
20852, (240) 669-5178, <a href="/cdn-cgi/l/email-protection#611200000508120e09210f080008054f0f08094f060e17"><span class="__cf_email__" data-cfemail="14677575707d677b7c547a7d757d703a7a7d7c3a737b62">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: February 1, 2024.
Lauren A. Fleck,
Program Analyst,Office of Federal Advisory Committee Policy.
[FR Doc. 2024-02436 Filed 2-6-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 7, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.